Q1 FY27 loss widens to Rs 8.14L; revenue drops to zero

Revenue DeclinePat NegativeResults View source PDF Explain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-4.2%Reaction day

₹0.96

prior close

—

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used+0.4%-4.6% vs market

Plastic Products - Industrial peers, median of 36sector-0.7%-3.5% vs sector

On the reaction day the stock moved 4.6 pts less than Nifty Microcap 250 and 3.5 pts less than its Plastic Products - Industrial peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

—

10m

—

15m

—

30m

—

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-4.2+0.4-4.6-0.7-3.5

Next day

-8.3+1.7-10.1-0.7-7.6

-7.3+2.1-9.4+0.0-7.3

-5.2+2.1-7.3-0.9-4.3

-10.4+2.1-12.5-1.4-9.1

-10.4+1.9-12.3-1.5-8.9

-11.5+2.4-13.9-1.1-10.4

15d

-13.5+3.0-16.6-1.2-12.3

-10.4+3.7-14.1+0.1-10.5

-17.7+1.6-19.3-3.7-14.0

—————

UpDownMarket · Nifty Microcap 250Sector · Plastic Products - Industrial peers, median of 36Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Amerise Biosciences posted a net loss of Rs 8.14L in Q1 FY27 (Jun 2026) versus a loss of Rs 0.81L in Q1 FY26. Revenue from operations was zero this quarter, down from Rs 6.37L a year ago. Total expenses rose to Rs 8.14L from Rs 7.18L. Other equity is negative at Rs 121.10L as of Mar 2026, showing accumulated losses. EPS was minus Rs 0.01.

Likely market impact

Wider loss with no revenue. Negative reserves signal financial stress. High-risk small-cap stock.